(Q28601505)

English

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options

scientific article

In more languages

Statements

scholarly article

0 references

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options (English)

0 references

multiple sclerosis

0 references

object named as

Chiara Zecca

6

0 references

object named as

Caroline Pot

21

0 references

object named as

Claudio Gobbi

24

0 references

Renaud Du Pasquier

object named as

Renaud Du Pasquier

19

0 references

25

object named as

Ludwig Kappos

0 references

Cristina Granziera

1 reference

ORCID Public Data File 2021

Heinrich Mattle

17

object named as

Heinrich P Mattle

0 references

Krassen Nedeltchev

10

object named as

Krassen Nedeltchev

0 references

author name string

Giulio Disanto

1

0 references

Pascal Benkert

2

0 references

Johannes Lorscheider

3

0 references

Stefanie Mueller

4

0 references

Jochen Vehoff

5

0 references

Simon Ramseier

7

0 references

Lutz Achtnichts

8

0 references

Oliver Findling

9

0 references

Ernst-Wilhelm Radue

11

0 references

Till Sprenger

12

0 references

Christoph Stippich

13

0 references

Tobias Derfuss

14

0 references

Jean-François Louvion

15

0 references

Christian P Kamm

16

0 references

Christoph Lotter

18

0 references

Myriam Schluep

20

0 references

Patrice H Lalive

22

0 references

Özgür Yaldizli

23

0 references

Jens Kuhle

26

0 references

language of work or name

0 references

publication date

2016

0 references

0 references

11

0 references

3

0 references

e0152347

0 references

copyright license

Creative Commons Attribution 4.0 International

31 March 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Defining the clinical course of multiple sclerosis: the 2013 revisions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

17 March 2017

Body fluid biomarkers in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

17 March 2017

GBD 2010: design, definitions, and metrics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

17 March 2017

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

17 March 2017

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

17 March 2017

Multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

17 March 2017

The immunopathology of multiple sclerosis: an overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

17 March 2017

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

17 March 2017

Alemtuzumab: a new therapy for active relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Immunology of relapse and remission in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM. Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Me

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

From the Gothenburg cohort to the Swedish multiple sclerosis registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Methods in comparative effectiveness research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Radiologically isolated syndrome--incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Age and disability accumulation in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

The changing demographic pattern of multiple sclerosis epidemiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

29 September 2017

Multiple sclerosis immunology: The healthy immune system vs the MS immune system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

3 June 2018

Natalizumab therapy for multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0152347

21 January 2018

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0152347

21 January 2018

The Danish Multiple Sclerosis Registry.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0152347

21 January 2018

Relapsing-remitting and primary progressive MS have the same cause(s)--the neuropathologist's view: 1.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0152347

21 January 2018

Relapsing-remitting and primary progressive MS have the same cause(s)--the neuropathologist's view: 2.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0152347

21 January 2018

Onset of secondary progressive phase and long-term evolution of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0152347

21 January 2018

The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4816556

27 November 2018

Identifiers

10.1371/JOURNAL.PONE.0152347

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2016PLoSO..1152347D

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28601505&oldid=1951859838"